To determine the influence of weight reduction on plasma lipoproteins, studies were carried out in 15 nondiabetic patients of varying degrees of obesity and four obese insulin-dependent diabetics. All studies were carried out on a metabolic ward and patients underwent three dietary periods: Period 1,4 to 5 weeks of weight maintenance in the obese state; Period II, caloric restriction to 1000 kcal/day to a weight loss of within 10% of ideal body weight; and Period III, again weight maintenance for 4 to 5 weeks near ideal body weight. Similar results were obtained for both nondiabetics and diabetics. Many patients had mildly elevated plasma triglycerides in Period I; they fell to the normal range in Period II and remained low in Period III. Total cholesterol levels decreased early in Period II, but levels began to rise near the end of caloric restriction, and in Period III, they were similar to Period I. Low density lipoprotein cholesterol levels followed a pattern similar to that of total cholesterol. High density lipoprotein cholesterol was relatively low in Period I (38 ± 2 mg/dl ± SEM); throughout weight loss, levels tended to rise, and in Period III, the average high density lipoprotein cholesterol was significantly higher (46 ± 2 mg/dl).
D espite many studies on the influence of diet on plasma lipids, 1 the effects of obesity and weight reduction on plasma lipoproteins have not been examined systematically and in detail. Excess body fat has been reported to-adversely affect several lipoprotein fractions; specifically, obesity has been claimed to increase plasma levels of very low density lipoproteins (VLDL), 2 " 5 to raise low density lipoproteins (LDL), 6 " 9 and to reduce high density lipoproteins (HDL). 710 It is commonly assumed that the metabolic effects of obesity can be reversed by weight loss. Previous work, in fact, has demonstrated that weight reduction will lower VLDL; 4 ' 5 but the degree of lowering has not been worked out completely. A reduction in LDL also has been reported; 6 ' 7 the extent of reduction nevertheless remains to be defined. Finally, a rise in HDL with weight loss might be expected, and indeed has been claimed, 71112 although not demonstrated conclusively. The pres-ent study was carried out to determine the effects of obesity, caloric restriction in obese subjects, and weight maintenance after weight loss on the patterns of change in each of these lipoprotein fractions.
Methods

Patients
The patients of this study were hospitalized throughout the investigation on the Special Diagnostic and Treatment Unit, Veterans Administration Medical Center, and on the General Clinical Research Center of Scripps Clinic and Research Foundation, San Diego, California. Informed consent was obtained from all patients.
Nondiabetic Patients
Fifteen obese patients (12 men, 3 women) were studied. They all had normal glucose tolerance according to the criteria of the National Diabetes Data Group. 13 The clinical characteristics, along with caloric intakes and degree of weight loss (see below), are shown in Table 1 . Their ages ranged from 39 to 60 years. Their body weights varied from 74 to 143 kg; these weights corresponded to a range of 123% to 209% of ideal body weight (IBW) according to the Metropolitan Life Insurance tables of 1959 (assuming a medium body frame). On the basis of the percentage of IBW, two subgroups were identified to determine whether the response to weight loss de- pended on the initial degree of obesity. Patients 1 to 7 (over 150% IBW; range 156% to 209% IBW) were designated as markedly obese. Patients 10 to 15 (123% to 128% IBW) were called mildly obese. The patients of this study were chosen not to have significant hyperlipidemia, although in retrospect, one patient (No. 13) probably had a primary hyperlipidemia (see Results). None of the patients had hypertension, or disease of the endocrine system, gastrointestinal tract, or liver.
Diabetic Patients
Four male diabetic patients also were studied. Their ages ranged from 49 to 61 years; their body weights were between 92 and 114 kg (128% to 154% ideal body weight (IBW)). The duration of diabetes was from 5 to 20 years. All had increased blood pressure at the outset; blood pressure became normal in each patient during weight loss, and it remained low throughout the study.
Experimental Design and Diets
All studies were carried out on the metabolic ward, and included three dietary periods. Period I lasted 4 to 5 weeks during which time the patients' weights were held constant in the obese state. In Period II, total calories were restricted to 1000 kcal/day; the patients were kept on this diet until they lost weight to an average of 110% IBW. Weight maintenance was reestablished at the lower weight for another 4 to 5 weeks (Period III). Throughout the study, blood was drawn for analysis of plasma total-and lipoproteinlipids (cholesterol and triglycerides) twice weekly.
The patients were fed on a liquid formula diet for the entire study. This diet contained 15% of calories as milk protein, 45% as dextrose, and 40% as fat, mostly in the form of lard. The distribution of fat calories among each category of fatty acids was 40% from saturated fatty acids, 50% from monounsaturates, and 10% from polyunsaturates. The polyunsaturated/saturated fat (P/S) ratio was 0.25. This liquid diet was prepared by Hospital Diet Products, Organon Corporation, Buena Park, California (courtesy of Mr. Alfred Teixeira). It contained approximately 50 mg cholesterol per 1000 kg. In Periods II and III small quantities of cholesterol were added to the liquid diet to equal cholesterol intakes in Period I. Thus, cholesterol intakes for most patients were in the range of 200 to 250 mg per day for all three periods. Vitamin and mineral supplements were given daily.
In Periods I and III the number of calories required to maintain constant weight was projected from the data of Ahrens, 14 as well as from our own data, developed from patients consuming liquid formula diets on a metabolic ward. Our patients were weighed daily; in both periods caloric intakes were adjusted to keep weight to within one kilogram of the weight obtained after the first week of the period. The amounts required to maintain constant weight during Periods I to III are given in Table 1 . For markedly obese patients (Nos. 1 to 7, more than 150% IBW), intakes in Period I ranged from 26.4 to 30.0 kcal/kg/day; for the mildly obese (Nos. 10 to 15, less than 130% IBW), they varied between 29.2 to 31.5 kcal/kg/day. In Period II total calories were restricted to 1000 kcal/day. The patients lost varying amounts of weight depending on the initial degree of obesity. Weight losses accrued at expected rates of about 1 kg per week, except that markedly obese patients lost more rapidly during the first portion of the caloric-restriction period. Most of those with marked obesity lost to within the range of 109% to 119% IBW (mean 114%). The remainder of nondiabetics fell to below 110% IBW. In Period III, weights were kept at the low achieved during weight loss. Caloric intakes in Period III were consistently higher than in Period I, ranging from 28.6 to 38.5 kcal/kg/day (mean = 31.8 ± 2.5 SD kcal/kg/day).
Diabetic patients were treated with enough long acting insulin during Period I to keep their fasting plasma glucose below 130 mg/dl. In Period II, when patients were on 1000 kcal/day, insulin was withdrawn altogether. In Period III, one patient had to be restarted on smaller doses of insulin to maintain the plasma glucose in the same range as in Period I; the other three did not require insulin in Period III.
Plasma Llplds and Llpoproteins
Fasting blood samples were taken after an overnight fast (14 hours) A tourniquet was used in phlebotomy. Total plasma cholesterol and triglycerides (TG) were determined on a Technicon AutoAnalyzer (Model II, Technicon Instruments Corporation, Tarrytown, New York). Concentrations of cholesterol in very low density lipoproteins (VLDL-C), low density lipoproteins (LDL-C), and high density lipoproteins (HDL-C) were estimated as described in the Lipid Research Clinics Manual of Laboratory Operations. 15 Triglycerides in HDL (HDL-TG) also were measured with the Autoanalyzer II.
Statistics
Statistical comparisons between each period were carried out by paired f test.
Results
Nondlabetlc Patients
The results for plasma lipids and lipoprotein cholesterol are presented for nondiabetic patients in Tables 2 to 7. The results for Periods I and III include the values for that portion of the period in which the concentrations appeared to be stabilized; this usually was the last 2 to 3 weeks of each period. Three means are shown for Period II. Period IIA was 3 to 5 weeks after starting weight reduction; for most patients this was the time of most rapid weight loss. Period MB was approximately 3 weeks at the midpoint of weight reduction; the weight lost to this point was about one-half the total lost. Period IIC was the last 2 to 3 weeks of caloric restriction just before a return to weight maintenance.
Plasma Triglycerides
Most obese patients had plasma TG in the uppernormal or mildly elevated range ( Table 2 ). The initial concentrations of TG did not correlate with the body weight or the percentage of IBW (r = 0.04). Caloric restriction usually produced a prompt decrease in plasma TG which persisted throughout Period II. The fall in TG levels did not correlate with the kilograms lost during Period II. In contrast, there was a significant correlation between the initial TG concentration and the decrease in plasma TG with weight loss (r = 0.74, p < 0.01). No rise in TG occurred when weight maintenance was reestablished at a lower weight (Period III). One patient (No. 13) failed to normalize his TG levels both during caloric restriction and after reestablishment of weight at a lower level; he apparently had a coexisting primary hypertriglyceridemia.
Plasma Total Cholesterol
None of the patients had distinct hypercholesterolemia during Period I (Table 3) . Patients with marked obesity had marginally lower levels than those with mild obesity (223 ± 11 vs 231 ± 15 mg/dl, respectively). Upon starting caloric restriction, total cholesterol levels commonly rose at the same time plasma TG concentrations were falling. Thereafter, total cholesterol usually decreased until it reached a low point near the middle of Period II; in most patients, levels then began to rise near the end of caloric restriction, although for the group as a whole, the levels were significantly lower in the last month of caloric restriction (Period IIC) than in Period I. With a return to weight maintenance at the lower weight, the levels rose still higher; and for the group of patients, the values for Period III were not significantly different from Period I (219 ± 9 vs 227 ± 7 mg/dl, respectively). Several patients with marked obesity (Nos. 1, 2, and 5) showed substantial reductions in Period III; but for all seven patients in this group, the average value for Period III was not significantly lower than that of Period 1,207 ± 15 vs 223 ±11, respectively). The same comparison for mildly obese patients also showed no difference (237 ± 13vs231 ± 15 mg/dl, respectively).
VLDL-Cholesterol
The levels of VLDL-C generally paralleled those of total TG, as seen in Table 4 . They fell significantly after starting caloric restriction, and they remained low throughout Periods II and III. In comparing Periods III and I, we found that the markedly obese patients showed a greater decrease (18 ± 3vs43 ± 8 mg/dl, respectively) than did the mildly obese (31 ± 9 vs 41 ±8 mg/dl). Data are expressed as mg/dl ± SD (number of samples); samples were taken twice weekly, and duration of each period can be estimated thusly.
Period I = Weight maintenance (obese state); Period II = caloric restriction (IIA = 1st portion of caloric restriction after initial changes; IIB = month of lowest total cholesterol; IIC = last month); Period III = weight maintenance (ideal weight).
Significance determined by paired t test (p < values). Table 2 .
LDL-Cholesterol
In Period I, plasma LDL-C ranged from 98 to 199 mg/dl (mean = 144 ± 7 mg/dl) ( Table 5) . None of the patients had LDL-C exceeding the 95th percentile of the general U.S. population. 16 The distribution and mean for LDL-C also were near those of the U.S. population of similar age and sex. 16 Whether our group is representative of the general population of obese people is unknown, but no attempt was made to exclude hypercholesterolemic patients during selection.
With the initiation of caloric restriction, the levels of LDL-C frequently rose simultaneously with the fall in plasma TG (data not shown); this response has been reported before by Wilson and Lees. 5 In our patients, the rise in LDL-C was transitory; it usually disappeared within 1 month of caloric restriction. At the midpoint of weight reduction, the levels reached their lowest. This trend, however, was reversed toward the end of weight reduction. In the last month of Period II, the mean concentration of LDL-C returned to the level of the obese state.
After a reestablishment of weight maintenance (Period III), the average LDL-C was similar to that of the obese state (151 ± 8 vs 144 ± 7 mg/dl, respectively). The levels in Period III (compared to Period I) also were similar for the markedly obese group (144 ± 16 vs 139 ± 13 mg/dl, respectively) and for the mildly obese patients (160 ± 13vs155 ± 8 mg/dl). Regardless of the initial degree of obesity, therefore, weight reduction did not lower LDL-C.
HDL-Cholesterol
The HDL-C in the obese state ranged from 27 to 52 mg/dl (mean 38 ± 2 mg) ( Table 6 ). The initial levels of HDL-C did not correlate with body weight or percentage of IBW (r = 0.177) in the obese state. They did, however, correlate with baseline TG levels (r = -0.59, p < 0.05). In the first month, despite a rapid fall in plasma TG, HDL-C concentrations did not rise (the mean for Period IIA was 37 ± 2 mg/dl). Throughout most of Period II, they remained unchanged, but toward the end of this period they began to rise (the mean for Period IIC was 44 ± 2 mg/ dl). After a reestablishment of weight maintenance (Period III), the average HDL-C (46 ± 2 mg/dl) was significantly higher than in Period I. A rise in HDL-C in Period III (compared to Period I) was observed in both the markedly obese group (46 ± 5 vs 40 ± 3 mg/dl, respectively) and the mildly obese group (46 ± 4 vs 37 ± 3, respectively, p < 0.02). Although mean values between Periods III and I were not significantly different for the small group of markedly obese patients, five of the seven had a significant increase in HDL-C in Period III when each was taken as his own control. Table 7 presents concentrations of HDL-TG in Periods I and III, along with ratios of TG/C in HDL. For the whole group, neither HDL-TG concentrations nor HDL-TG/C ratios were altered by weight reduction.
HDL-Triglycerides
LDL-C/HDL-C Ratios
Because of the rise in HDL-C with caloric restriction, the ratio of LDL-C to HDL-C frequently fell (Table 8). Nine of 15 patients had a statistically significant decrease in this ratio. Because LDL-C also increased in some patients, not all had a reduction in ratios, and the change for the whole group was not statistically significant.
Diabetic Patients
The results for the four diabetic patients are summarized in Table 9 . These patients generally followed the same pattern as nondiabetics. Plasma TG declined rapidly with caloric restriction and remained low in Period III. Total cholesterol and LDL-C were essentially unchanged by weight loss. HDL-C rose significantly in three of four patients, causing a decrease in the LDL-C/HDL-C ratio. Also, HDL-TG increased significantly in Period III compared to Period I. tNone of the individual patients had a significant change in this parameter compared to Period I. 4Three of four patients had a significant increase in HDL-C (Compared to Period I); one did not.
§HDL-TG was significantly higher in Period III than in Period I (p < 0.05).
Discussion
This investigation examined the effects of weight reduction on plasma lipids and lipoproteins of obese patients with and without diabetes. All studies were done on a metabolic ward so that the composition of the diet and the intakes of dietary cholesterol could be held constant. Any changes in plasma lipoproteins thus should be related entirely to a decrease in caloric intake and adipose tissue mass. A different design might have produced different results. The patients in this study had variable degrees of obesity. Our examination of these subgroups, however, re-vealed no major differences in their response to weight loss. Also, nothing unique was found in the diabetic group. All the patients, therefore, can be considered as a single group.
Caloric consumption in the obese state generally was high, although intakes expressed per kilogram of total body weight were lower than in most nonobese subjects. 1 * Interestingly, caloric requirements after weight loss (mean = 31.8 ± 2.5, SD kcal/kg/ day) were lower than those reported previously by Ahrens 14 for nonobese subjects who had never been obese; in his 71 adult men, the mean caloric intakes required to maintain constant weight were 35.8 ± 3.9 kcal/dg/day. The reasons for a relatively low requirement in previously obese patients are not apparent; these patients may simply be less active physically, even after weight reduction, than normal subjects.
In the following discussion, the effects of weight reduction on the major lipoprotein fractions will be considered. Particular attention will be given to the changes noted in the present investigation.
Very Low Density Llpoprotelns
Obesity is known to increase plasma TG levels. The major mechanism for this effect is increased synthesis of VLDL-TG. 3 ' 17> 18 The response of plasma VLDL-TG to obesity is accentuated when patients have an underlying defect in TG clearance. 17 ' 18 All our patients except one (No. 13) had a TG level below 350 mg/dl in their obese state; this suggests that they did not have a significant defect in clearance plasma TG before weight loss. Immediately after starting caloric restriction, TG levels generally fell to the normal range. Levels remained low throughout the second period. The fall in TG was likely due mainly to a reduction in synthesis of VLDL-TG; 34 the causes could have been decreased availability of substrate for TG synthesis and/or reduced concentrations of circulating insulin. 3 An increased clearance due to greater lipoprotein lipase also may have been a factor. 12 The plasma TG remained low after return to weight maintenance in Period III. Low levels persisted despite intakes of total calories only slightly below baseline amounts. Thus, the effects of obesity on TG levels probably cannot be explained simply by a high caloric intake. The higher TG must be related in some way to the obese state. Whether this phenomenon is the result of a lessened peripheral resistance to insulin by weight loss must be studied further. 4 ' 1B The extent to which obesity raised TG levels was variable; it was not correlated with the degree of obesity. However, the patients with the highest initial levels of TG generally had the greatest reductions with weight loss. Not all the obese patients had elevated TG; this finding is in accord with a previous report from our laboratory that some obese subjects with overproduction of VLDL-TG are protected from high TG by enhanced clearance. 3 The fall in TG level with weight loss was associated with a corresponding decrease in VLDL-C; the reduction of the latter averaged 22 mg/dl, which is equivalent to about 10% of total cholesterol. This percentage decrease may have some significance in view of the claim of Carlson et al. 19 '
x that high plasma VLDL-C is an independent risk factor for coronary heart disease (CHD).
Low Density Llpoprotelns
A primary focus of the present study was the influence of obesity and weight loss on levels and metabolism of LDL. Perhaps the most striking finding was a lack of decline in LDL-C with weight restriction. This failure of response was unexpected. Several previous reports suggested that a different effect would be obtained. Olefsky et al. 4 carried out weight reduction in 36 patients with varying levels of plasma lipids. In their study, TG concentrations fell consistently. Mean total cholesterol also declined by 21%; individual lipoprotein classes were not measured. Galbraith et al. 21 induced weight loss over a relatively short period in six markedly obese patients; total cholesterol fell by an average of 27%. Brownell and Stunkard 6 examined the influence of moderate weight reduction (but not to ideal weight) in another group of obese patients; weight loss in these patients lowered LDL-C concentrations significantly. Finally, Contaldo et al. 7 claimed that weight loss reduced LDL-C concentrations in seven obese subjects. Their patients lost an average of 21 kg; after stabilization at a lower weight, LDL-C was significantly lower than before weight loss.
Why did we obtain different results? First, our patients' weights were reduced to nearly ideal levels. In some cases concentrations of LDL-C fell during caloric restriction. Their levels did not rebound to values found in the obese state until the patients neared their ideal weight. Some of the previously studied patients may not have lost enough weight to reveal this rebound phenomenon. Others may have been in a negative caloric balance at termination of their trial. Second, we studied patients on the metabolic ward where diet composition was controlled rigorously. Throughout the entire study no changes were allowed in type of fat ingested, in amounts of dietary cholesterol, or in the overall nutrient composition of the diet. In prior work these factors may not have been controlled as tightly. Finally, we made no attempt to determine whether weight loss will lower LDL-C in patients with primary hypercholesterolemia. We have not ruled out the possibility that patients with familial combined hyperlipidemia 22 -23 or polygenic hypercholesterolemia 22 a would show a reduction of LDL-C after the loss of excess adipose tissue. Further studies are needed to address this important question.
How can we explain the failure of weight loss to lower LDL? Since VLDL is a precursor of LDL, 2425 high production rates of VLDL in the obese state might be expected to increase the formation of LDL. A decrease in VLDL synthesis with weight loss likewise should lower the amounts of VLDL available for transformation to LDL; if so, LDL levels should fall. Surprisingly, the latter did not occur. An explanation for the lack of decline in LDL levels may be provided by another study from our laboratory. 26 The latter showed that the synthesis of LDL in the obese state is increased; at the same time, however, the clearance of LDL also is enhanced. The total flux of LDL thus is elevated, even when concentrations are not. The result could be an increased risk for CHD; a recent study from our laboratory showed that nonobese patients with CHD often have enhanced flux of LDL without hypercholesterolemia. Weight reduction probably decreases both the input and the clearance of LDL, leaving the concentrations unchanged. Nonetheless, a reduced flux could lessen the risk for CHD.
The results during the last month of caloric restriction (Period IIC) were revealing in another context. Concentrations of LDL-C in patients of similar weight and diet ranged from 96 to 215 mg/dl (mean ± SD = 145 ± 27 mg/dl). All patients had been on low intakes of cholesterol and total calories for a long period; variations in their LDL levels at this time presumably were due to individual genetic differences. Genetic variability was not surprising; the relatively high values for LDL-C seen in many patients on a minimal diet, however, were not anticipated. The levels in some of our patients were not nearly as low as found in other racial groups. 27 ' a Genetic and racial factors, and not altogether diet, therefore, may be responsible for the relatively high plasma LDL found in many Caucasians.
High Density Llpoprotelns
Gordon et al. 10 and others have reported an inverse association between body weight and plasma HDL-C. Our findings are in agreement; most of the patients had relatively low HDL-C in their obese state. Weight reduction, furthermore, produced an increase in HDL-C levels. A rise in HDL-C with weight loss has been reported previously, 71112 although the time course of the change seems particularly well defined in the current work.
How can the rise in HDL-C with weight loss be explained? A connection with the metabolism of plasma TG must be explored. Patients with primary hypertriglyceridemias often have low HDL-C. This is due in part to an exchange between TG in VLDL and cholesterol ester in HDL; the result is a high HDL-TG and a low HDL-C. 30 In hypertriglyceridemia the number of HDL particles is not necessarily reduced; in some cases only the TG/C ratio in HDL has been increased. This mechanism was ruled out for our obese patients. They did not have a high HDL-TG/C ratio before weight loss, and the ratio did not rise afterwards. Also, their VLDL-TG levels in Period II fell long before HDL-C began to rise. A more complex relationship between metabolism of VLDL-TG and HDL-C still may exist. One possibility has been suggested by Schwartz and Brunzell. 12 these workers measured the activity of adipose tissue lipoprotein lipase before and after weight loss in a group of obese patients. The activity of this enzyme was found to increase after weight stabilization at a reduced weight. With weight reduction, plasma HDL-C also increased significantly. These investigators suggested that the rise in HDL-C may be mediated by enhanced activity of adipose tissue lipoprotein lipase.
An alternative hypothesis for the low HDL-C with obesity might be considered, however; the obese state could be associated with a high rate of catabolism of HDL; a parallel rise in HDL-C and LDL-C near the end of caloric restriction is consistent with the concept that excess adipose tissue accelerates catabolism of both lipoproteins. This hypothesis seems to fit the time course of the rise in these two lipoproteins better than does one involving a change in TG metabolism. No increase in HDL-C levels was noted during the early phase of caloric restriction even though TG levels had returned to normal; only later, after most excess adipose tissue had been removed, did HDL levels begin to rise.
An important question arising from these results is whether the increase in HDL-C levels, and the decrease in LDL-C/HDL-C ratios in many patients, associated with weight loss, reduces the risk for CHD. 10 This question remains to be answered. The present work nonetheless demonstrates that a substantial increase in HDL-C can be achieved by weight reduction.
